Company page

Xcell Therapeutics, Inc.

Xcell Therapeutics, Inc. is a public company traded under the ticker 373110 on the Korean market. The company has a market capitalization of approximately 19.79 million. Xcell Therapeutics focuses on developing innovative therapeutic solutions.

profile373110AI content: aiUpdated May 30, 2026/company/xcell-therapeutics-inc
Xcell Therapeutics, Inc. logo
Ticker
373110
Market cap
$19.8M
Sector
Health Technology
Industry
Biotechnology